FcεRI and MRGPRX2 differentially regulate mast cell degranulation dynamics

被引:0
|
作者
Gaudenzio, N. [1 ]
机构
[1] Univ Toulouse, Hop Purpan, INSERM, UDEAR,UMR 1056, Pl Dr Baylac,TSA 40031, F-31059 Toulouse 9, France
来源
REVUE FRANCAISE D ALLERGOLOGIE | 2018年 / 58卷 / 02期
关键词
Mast cells; IgE; Substance P; Fc epsilon RI; MRGPRX2; Granular content; Inflammation; SECRETORY GRANULES; IMMUNOGLOBULIN-E; IGE; IDENTIFICATION; RESISTANCE; BASOPHILS; IMMUNITY; RECEPTOR; PROMOTE; DEFENSE;
D O I
10.1016/j.reval.2018.01.001
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mast cells are granular immune cells strategically located among connective tissues and mucosa, where they participate to the regulation of diverse inflammatory processes. The principal characteristic of mast cells is their capacity to rapidly exteriorize intracellular granular content enriched in bioactive molecules in response to different activation signals. A better understanding of how these cells regulate their secretion dynamics under different stimulatory conditions is crucial to apprehend mast cell-dependent inflammatory reactions. We particularly focused on mast cell activation via two major receptors involved in diverse pathophysiological processes: Fc epsilon RI (the high affinity receptor for IgE) and MRGPRX2 (the mast cell receptor for cationic molecules). To circumvent existing technical constraints, we developed a new approach that permits to monitor, in real-time and at the single cell level, mast cell degranulation dynamics using in vitro confocal microscopy and in vivo two-photon microscopy. We found that mast cell translate Fc epsilon RI- or MRGPRX2-mediated signals into distinct degranulation strategies leading to the release of granular content with specific physical characteristics and the development of mast cell-dependent reactions of different intensities. Here we propose a synthesis of new concept on how mast cells regulate their degranulation strategy in response to activation via different receptors. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [1] Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist
    Bawazir, Maram
    Amponnawarat, Aetas
    Hui, Yvonne
    Oskeritzian, Carole A.
    Ali, Hydar
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Mast cell degranulation via MRGPRX2 by isolated human albumin fragments
    Karhu, T.
    Akiyama, K.
    Vuolteenaho, O.
    Bergmann, U.
    Naito, T.
    Tatemoto, K.
    Herzig, K. -H.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (11): : 2530 - 2534
  • [3] Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis
    Elst, Jessy
    De Puysseleyr, Leander P.
    Ebo, Didier G.
    Faber, Margaretha A.
    Van Gasse, Athina L.
    van der Poorten, Marie-Line M.
    Decuyper, Ine I.
    Bridts, Chris H.
    Mertens, Christel
    Van Houdt, Michel
    Hagendorens, Margo M.
    De Clerck, Luc S.
    Verlinden, Anke
    Vermeulen, Katrien
    Maes, Marie-Berthe
    Berneman, Zwi N.
    Valent, Peter
    Sabato, Vito
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis?
    Wang, Zhao
    Babina, Magda
    [J]. EXPERIMENTAL DERMATOLOGY, 2020, 29 (11) : 1104 - 1111
  • [5] MRGPRX2 Small Molecule Antagonists Potently Inhibit Agonist-Induced Skin Mast Cell Degranulation
    Frischbutter, S.
    Wollam, J.
    Solomon, M.
    Villescaz, C.
    Evans, S.
    Freeman, D.
    Vasquez, A.
    Pisacane, C.
    Vest, A.
    Napora, J.
    Charlot, B.
    Cavarlez, C.
    Kim, A.
    Viswanath, V.
    Metz, M.
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [6] MRGPRX2 small molecule antagonists potently inhibit agonist-induced skin mast cell degranulation
    Wollam, J.
    Solomon, M.
    Villescaz, C.
    Anderson, S.
    Freeman, D.
    Vasquez, A.
    Pisacane, C.
    Vest, A.
    Napora, J.
    Charlot, B.
    Cavarlez, C.
    Kim, A.
    Dvorak, L.
    Lanier, M.
    Selfridge, B.
    Huang, L.
    Saenz, M.
    Brooks, J.
    Nevarez, A.
    Dedman, H.
    Timony, G.
    Martinborough, E.
    Viswanath, V.
    Boehm, M.
    [J]. ALLERGY, 2023, 78 : 204 - 204
  • [7] Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions
    Chaki, Shaswati
    Amponnawarat, Aetas
    Levenstein, Brett
    Hui, Yvonne
    Oskeritzian, Carole
    Ali, Hydar
    [J]. ALLERGY, 2024, 79 (03) : 758 - 761
  • [8] In Vivo Mast Cell Activation by the MRGPRX2 Receptor Ligands
    Shtessel, Maria
    Oliver, Eric T.
    Chichester, Kristin L.
    Saini, Sarbjit Singh
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB35 - AB35
  • [9] MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway
    Babina, Magda
    Wang, Zhao
    Roy, Saptarshi
    Guhl, Sven
    Franke, Kristin
    Artuc, Metin
    Ali, Hydar
    Zuberbier, Torsten
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : 1286 - +
  • [10] MRGPRX2 Small Molecule Antagonists Potently Inhibit Agonist-Induced Skin Mast Cell Degranulation
    Wollam, Joshua
    Solomon, Michelle
    Villescaz, Christiane
    Evans, Samantha
    Freeman, David
    Bacon, Corinne
    Frischbutter, Stefan
    Metz, Martin
    Vest, Alan
    Napora, Jim
    Charlot, Brittney
    Cavarlez, Christine
    Kim, Andrew
    Viswanath, Veena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB62 - AB62